Clinical trial
Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled Study
NCT05545605 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled Study
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 116 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.